MetaADEDB 2.0 @ LMMD
fluindione
(NASXCEITKQITLD-UHFFFAOYSA-N)
Structure
SMILES
O=C1C(c2ccc(cc2)F)C(=O)c2c1cccc2
Type(s)
Approved; Investigational
ATC code(s)
B01AA12
Molecular Formula:
C15H9FO2
Molecular Weight:
240.229
Log P:
2.9885
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
34.14
CAS Number(s):
957-56-2
Synonym(s)
1.
fluindione
2.
2-(4-fluorophenyl)-1,3-indanedione
3.
Previscan
External Link(s)
MeSHC017673
PubChem Compound68942
BindingDB50280156
ChEBI134975
CHEMBLCHEMBL24924
DrugBankDB13136
DrugCentral1194
KEGGdr:D07969
ZINC100091724
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Accidental overdoseOFFSIDES
2AcidosisOFFSIDES
3Acute kidney injury

View details

16221711
17176918
18417438
19357010
 		CTD
4Alanine Aminotransferase IncreasedOFFSIDES
5Albuminuria17176918CTD
6AmphetaminesOFFSIDES
7AngioedemaOFFSIDES
8Antibiotic level above therapeuticOFFSIDES
9Application site reactionOFFSIDES
10AspergillosisOFFSIDES
11Aspiration PneumoniaOFFSIDES
12Atrial Fibrillation16221711CTD
13Blood alkaline phosphatase increasedOFFSIDES
14Blood creatinine increasedOFFSIDES
15Blood pressure immeasurableOFFSIDES
16Blood sodiumOFFSIDES
17Body TemperatureOFFSIDES
18BradycardiaOFFSIDES
19Bulbar palsyOFFSIDES
20Cardiac TamponadeOFFSIDES
21Cardioactive drug level above therapeuticOFFSIDES
22Cell DeathOFFSIDES
23Chemical and Drug Induced Liver Injury12666267CTD
24Choking sensationOFFSIDES
25Cholestasis12666267CTD
26ConfabulationOFFSIDES
27CyanosisOFFSIDES
28Cytolytic hepatitisOFFSIDES
29Disease recurrenceOFFSIDES
30Dyspnea19357010CTD
31EczemaOFFSIDES
32Eosinophilia17176918CTD
33EpistaxisOFFSIDES
34ErysipelasOFFSIDES
35ErythemaOFFSIDES
36Escherichia infectionOFFSIDES
37Eyelids pruritusOFFSIDES
38Febrile bone marrow aplasiaOFFSIDES
39Fever17176918
19357010
21284358		CTD
40Fluid overloadOFFSIDES
41Gamma-Glutamyltransferase IncreasedOFFSIDES
42GammopathyOFFSIDES
43GranulomaOFFSIDES
44HaemoconcentrationOFFSIDES
45Hematuria17176918CTD
46Hemorrhage17176918CTD
47HepatitisOFFSIDES
48Hepatojugular refluxOFFSIDES
49HepatosplenomegalyOFFSIDES
50HypocomplementaemiaOFFSIDES
51HypoxiaOFFSIDES
52Kidney Diseases21284358CTD
53Kidney FailureOFFSIDES
54LaryngospasmOFFSIDES
55Liver diseases21284358CTD
56Lymphatic Diseases19357010CTD
57Muscle necrosisOFFSIDES
58Nephritis allergicOFFSIDES
59Nephritis, Interstitial

View details

1754986
16221711
17176918
18417438
19357010
 		CTD
60Nephrosclerosis16221711CTD
61OrthopneaOFFSIDES
62OverdoseOFFSIDES
63PROTHROMBIN TIMEOFFSIDES
64Pain of skinOFFSIDES
65Peritoneal InfectionOFFSIDES
66Phlebitis16221711CTD
OFFSIDES
67Postrenal failureOFFSIDES
68Proteinuria16221711CTD
69Prothrombin level decreasedOFFSIDES
70Prothrombin time ratio decreasedOFFSIDES
71Pulmonary arterial hypertensionOFFSIDES
72QuadriparesisOFFSIDES
73QuadriplegiaOFFSIDES
74RhabdomyolysisOFFSIDES
75Skin lesionOFFSIDES
76Skin necrosisOFFSIDES
77Status EpilepticusOFFSIDES
78ThrombectomyOFFSIDES
79Thrombocytopenia1754986CTD
80Tonic clonic movementsOFFSIDES
81Transaminases increasedOFFSIDES
82Venous Thromboembolism17176918CTD
83Vestibular NeuronitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.